Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1994684 | 0.70 | CRHBP (0.63) | CRHBPCRHR2ALDH1A1 | |
| Nitric Acid SCHEMBL8647053 | 0.69 | CRHBP (0.57) | CRHBPCRHR2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9247859 | 0.69 | CRHBP (0.61) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL3476909 | 0.66 | CRHBP (0.38) | CRHBPCRHR2 | |
| SCHEMBL17484752 | 0.66 | ALDH1A1 (0.41) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL6365346 | 0.64 | ALDH1A1 (0.52) | ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL9251412 | 0.63 | CRHBP (0.49) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL9921596 | 0.62 | GAA (0.38) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL6366107 | 0.62 | APEX1 (0.36) | ALDH1A1 | |
| SCHEMBL5598058 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7829729-B2 | 1-glycidyl-3,3-dinitroazetidine containing explosive moiety and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2010-11-09 | — | — | US | claimed |
| US-20090299079-A1 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2009-12-03 | — | — | US | claimed |
| US-7829729-B2 | 1-glycidyl-3,3-dinitroazetidine containing explosive moiety and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2010-11-09 | — | — | US | disclosed |
| US-20090299079-A1 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299079-A1 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF | DNMT1, DNMT3A, HBZ | CRHBP 3060/4885CRHR2 4140/4885ALDH1A1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.